Dimethylacetamide Market size was USD 113.07 million in 2024 and is estimated to reach USD 166.1 million by the end of 2037, expanding at a CAGR of 2.6% during the forecast period, i.e., 2025-2037. In 2025, the industry size of dimethylacetamide is evaluated at USD 116 million.
The global dimethylacetamide market will expand significantly due to its widespread application in fiber production for the textile sector. In the fiber and textile industry, dimethylacetamide is a crucial substance. DMAc is a multipurpose substance with outstanding qualities like high solvency, regulated viscosity, and chemical and thermal stability. It is essential to the wet spinning of polyacrylonitrile, another name for acrylic fibers. These fibers are extensively utilized in various textiles, such as industrial fibers, blankets, carpets, rugs, sportswear, and clothing. Furthermore, the chemical is used in synthetic fibers like nylon and polyurethane in addition to acrylic.
The Textile Exchange reported that since 2000, the world's fiber production has more than doubled. The 124 million tons from the previous year is a 7% increase from the 116 million tons in 2022, and if current trends continue, they are predicted to reach 160 million tons in 2030. Also, in 2023, 75 million tons of virgin fossil-based synthetic fibers were produced, up from 67 million tons in 2022. With 57% of all fiber production, polyester remains the most produced fiber in the world. Recycled fibers accounted for just 2% of the overall market share for polyamide (nylon), the second most popular synthetic fiber. Therefore, the growing production of these fibers is consequently driving the dimethylacetamide.
Dimethylacetamide, commonly referred to as DMA or DMAc, is a clear liquid that is water-soluble. It is predominantly utilized as an industrial solvent for a diverse array of organic and inorganic compounds, owing to its characteristics as a dipolar aprotic solvent. The synthesis of dimethylacetamide occurs through the reaction of dimethylamine and methyl acetate at temperatures exceeding 95 degrees Celsius, with the assistance of sodium methoxide.
As the supply of dimethylamine increases, manufacturers are positioned to enhance the production of DMAc, thereby addressing the rising demand in various sectors. According to the Environmental Clearance, the global production capacity of dimethylamine is estimated to be between 2500 and 3000 metric tons per month annually. Moreover, several companies, including Arclin, Balaji Amines Limited, and Methanol Chemical Company, are actively expanding their production capacities for dimethylamine, which ensures a stable and cost-effective supply for the dimethylacetamide market.
Growth Drivers
Country |
Export Value of Polyvinyl Chloride (in USD Million) |
Country |
Import Value of Polyvinyl Chloride (in USD Million) |
U.S |
3270 |
India |
2320 |
China |
2560 |
Turkey |
1250 |
Chinese Taipei |
1350 |
Germany |
1040 |
Germany |
1260 |
Italy |
979 |
France |
1080 |
Vietnam |
821 |
Source: OEC
The Observatory of Economic Complexity (OEC) reported that polyvinyl chloride ranked as the 193rd most traded product worldwide, with a total trade of USD 17.8 billion in 2022. Polyvinyl chloride trade accounts for 0.075% of the global trade.
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
2.6% |
Base Year Market Size (2024) |
USD 113.07 million |
Forecast Year Market Size (2037) |
USD 166.1 million |
Regional Scope |
|
Application (Fibers, Adhesives, Pharmaceuticals, Dyes, Agrochemicals)
Pharmaceutical segment is set to dominate dimethylacetamide market share of around 45.2% by the end of 2037. Dimethylacetamide is utilized both as a solvent and as a reagent in the manufacturing of numerous medicinal products. It is employed as a solvent in the innovative X-ray contrast medium. The pharmaceuticals segment is anticipated to be driven by several variables, including trade liberalization, changes in sociodemographic, scientific, and technological advancements, and the need for medications.
The production of N, N Dimethylacetamide is expanding due to its widespread acceptance as a medication excipient in the formulation of many pharmaceutical products, such as Busulfex and Vumon. A chemotherapeutic drug called teniposide (marketed under the brand Vumon) is used to treat several cancers, including Hodgkin's lymphoma, juvenile acute lymphocytic leukemia (ALL), and some brain tumors. It suppresses the body's cancer cells' proliferation and belongs to a class of medications called podophyllotoxin derivatives. According to the National Institutes of Health, in 2019, there were 347,992 new cases of brain cancer worldwide. Therefore, the increasing prevalence of these conditions will proliferate the DMAc market growth. As a result of its chemical stability, it is also widely accepted in terms of inflammation and osteoclast generation.
Packaging Type (Glass Bottle, Tank, Drum)
The drum segment in dimethylacetamide market will garner a significant share during the assessed period. The substance is an organic chemical that is a colorless, water-soluble liquid used as a flexible solvent in various industrial processes, such as manufacturing organic materials, textiles, and medications. Usually composed of materials such as high-density polyurethane, this chemical is packaged and transported in big drums. The segment expansion may be fueled by the safe storage and transportation of liquid chemicals, which is ensured by the design of these barrels.
Our in-depth analysis of the global dimethylacetamide market includes the following segments:
Packaging Type |
|
Application |
|
APAC Market Statistics
Asia Pacific dimethylacetamide market is predicted to account for revenue share of more than 37.4% by the end of 2037. The growth of the market can be attributed to the rapid expansion of the region's industrial sector, encompassing textiles, chemicals, and pharmaceuticals. The increase in disposable income within the region is bolstering the demand for products such as apparel and furnishings that incorporate dimethylacetamide (DMAc). Dimethylacetamide Market growth and developments in the dimethylacetamide sector are further driven by the region's burgeoning population, which has escalated the demand for textiles and has prompted significant investments in pharmaceutical research and development. Moreover, governments in the Asia Pacific region are making substantial investments in manufacturing initiatives and infrastructure development, thereby creating an environment that is favorable for the production and application of DMAc.
In China, the dimethylacetamide market is driven by its robust textile and pharmaceutical industries, as well as government economic initiatives. Government policies aimed at stabilizing the real estate market and stimulating economic growth have also boosted industries that depend on DMAc. Additionally, the market saw some respite from its general downward trend when dimethylacetamide saw a modest plunge in the country due to government backing and a slight increase in production costs. The market had a minor 0.5% price gain in 2024, reaching USD 895/MT. The trend was also influenced by the moderate demand from downstream industries like construction and medicines.
Moreover, India's thriving pharmaceutical, textile, and electronics sectors are escalating the demand for DMAc in the nation. The textile industry's growth, fueled by the increasing production of synthetic fibers such as spandex, propels DMAc consumption. The International Fiber Journal stated that consumer demand for spandex-blended apparel has increased in recent years as a result of the versatility these garments provide. Seizing the chance, Indorama India, a division of the USD 25 billion Indorama Group, was the first to establish a spandex production facility in India in 2011 under the Inviya brand. In 12 years, Indorama India quadrupled its capacity from a modest 5,000 tons annually to 20,000 tons. The company's product line includes knits, spandex for woven and air-covered yarns, and specialty items like SnugFit for diapers and other hygiene goods.
North America Market Analysis
North America dimethylacetamide market is expected to grow at a significant rate during the projected period. The pharmaceutical industry's increasing need for dimethylacetamide as a reagent and preferred solvent is responsible for the market's expansion. DMAc is also utilized to make several medications since it is quickly absorbed through the mouth and skin. Additionally, it is anticipated that the growing need for fibers, films, and coatings will effectively propel the growth of the dimethylacetamide market in the region. In the U.S., the market is fueled by the increased demand for advanced drug formulations and the chemical industry’s focus on high-performance polymers and coatings. In 2023, the U.S. paint and coatings industry was valued at approximately USD 37.1 billion. By 2031, this value is expected to rise to almost USD 49.6 billion.
Numerous small and medium-sized businesses coexist with several major companies in the fiercely competitive dimethylacetamide market. These businesses are well-equipped to do research and development, and their wide range of products and distribution systems give them a significant market presence. There is fierce rivalry in the industry, and businesses are concentrating on growing their product lines and market share through partnerships, mergers, and acquisitions. Among the major participants in the dimethylacetamide market are
Author Credits: Rajrani Baghel
Copyright © 2025 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?